Table 4 Performance of participants in the traditional and ICAP nomenclature systems
Specimen ID | Traditional | Observations (n) | Accuracy (95% CI) | ICAP | Observations (n) | Accuracy (95% CI) |
|---|---|---|---|---|---|---|
ANA-005 | Centromere | 24 | 100 (86–100) | Centromere, AC-3 | 20 | 100 (83–100) |
ANA-002 | DND | 24 | 96 (73–99) | MND, AC-6 | 20 | 85 (60–95) |
ANA-003 | Speckled | 24 | 100 (86–100) | Nuclear CS, AC-5 | 18 | 67 (41–85) |
ANA-007 | Speckled | 24 | 96 (73–99) | Nuclear DFS, AC-2 | 20 | 80 (55–93) |
ANA-010 | Speckled | 24 | 83 (62–94) | Nuclear FS, AC-4 | 19 | 37 (18–61) |
ANA-011 | Speckled/Other | 24 | 42 (23–63) | Anti-topo I, AC-29 | 21 | 62 (39–81) |
ANA-006 | Nucleolar | 24 | 100 (86–100) | Homo nucleolar, AC-8 | 20 | 70 (46–87) |
ANA-004 | Cytoplasmic | 19 | 100 (86–100) | AMA, AC-21 | 19 | 89 (66–97) |
ANA-008 | Cytoplasmic | 20 | 90 (65–98) | Cytoplasmic DFS, AC-19 | 19 | 79 (53–92) |
ANA-009 | Cytoplasmic | 19 | 53 (30–74) | Cytoplasmic FS, AC-20 | 19 | 42 (22–66) |
ANA-001 | Mitotic | 22 | 86 (64–96) | Spindle fiber, AC-25 | 20 | 75 (50–90) |
ANA-012 | Mitotic | 24 | 92 (70–98) | NuMA-like, AC-26 | 22 | 95 (71–99) |
Overall | 250 | 87 (82–90) | Centromere, AC-3 | 237 | 74 (68–79) |